$198 Million is the total value of Atlas Venture Advisors, Inc.'s 5 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CBLK | CARBON BLACK INC | $137,032,000 | +3.9% | 9,823,103 | 0.0% | 69.18% | -0.6% | |
| TBIO | TRANSLATE BIO INC | $39,965,000 | +35.9% | 3,922,008 | 0.0% | 20.18% | +30.0% | |
| ZFGN | ZAFGEN INC | $9,607,000 | -44.6% | 3,506,207 | 0.0% | 4.85% | -47.1% | |
| MGEN | MIRAGEN THERAPEUTICS INC | $8,768,000 | -7.9% | 3,142,580 | 0.0% | 4.43% | -11.9% | |
| SNAP | SNAP INCcl a | $2,701,000 | +100.1% | 245,076 | 0.0% | 1.36% | +91.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SNAP INC | 20 | Q3 2023 | 6.1% |
| ROKU INC | 16 | Q3 2023 | 11.7% |
| LARIMAR THERAPEUTICS INC | 14 | Q3 2023 | 1.4% |
| TRANSLATE BIO INC | 11 | Q2 2021 | 52.9% |
| INTEGRAL AD SCIENCE HLDNG CO | 10 | Q3 2023 | 71.2% |
| BICYCLE THERAPEUTICS PLC | 10 | Q3 2021 | 25.2% |
| VIRIDIAN THERAPEUTICS INC | 10 | Q1 2023 | 2.1% |
| F-STAR THERAPEUTICS INC | 9 | Q4 2022 | 1.3% |
| DRAFTKINGS INC | 8 | Q1 2022 | 82.5% |
| MIRAGEN THERAPEUTICS INC | 8 | Q3 2020 | 5.0% |
View Atlas Venture Advisors, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-02 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-08 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-01-27 |
| 13F-HR | 2021-11-04 |
View Atlas Venture Advisors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.